Effect of in vivo administration of anti-CLTA-4 mAb and stimulatory anti-CD40 mAb on the induction of low dose oral tolerance

被引：0
|
作者：
Burns, R [1 ]
Rappold, K [1 ]
机构：
[1] Thomas More Coll, Crestview Hills, KY 41017 USA
来源：
FASEB JOURNAL | 2005年 / 19卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A949 / A949
页数：1
相关论文
共 50 条
  • [1] The Use of Anti-CD40 mAb in Cancer
    Remer, Marcus
    White, Ann
    Glennie, Martin
    Al-Shamkhani, Aymen
    Johnson, Peter
    CANCER VACCINES, 2017, 405 : 165 - 207
  • [2] Effect of in vivo administration of anti-CTLA-4 mAb and IL-12 on low dose oral tolerance.
    Barone, KS
    Murray, S
    Qualls, J
    FASEB JOURNAL, 2002, 16 (04): : A284 - A284
  • [3] Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb
    Ito, D
    Ogasawara, K
    Iwabuchi, K
    Inuyama, Y
    Onoé, K
    JOURNAL OF IMMUNOLOGY, 2000, 164 (03): : 1230 - 1235
  • [4] Preclinical Characterization Of a Humanized Antagonistic Anti-CD40 Mab
    Ralph, Kerry
    Nicoletti, Amy
    Musvasva, Eunice
    Cannan, Susan
    VanTongeren, Susan
    Blanset, Diann
    Brodeur, Scott
    Ahlberg, Jennifer
    Li, Hua
    Fogal, Steve
    Desai, Sudha
    O'Shea, Kathy
    Kroe-Barrett, Rachel
    Nabozny, Gerald
    Wu, Helen
    Hansen, Gale
    Canada, Keith
    Singh, Sanjaya
    Ramanujam, Meera
    Grimaldi, Christine
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S16 - S16
  • [5] Manipulation of macrophage populations can enhance low dose radiation plus anti-CD40 MAB
    Honeychurch, J
    Glennie, MJ
    Johnson, PWM
    Illidge, TM
    BRITISH JOURNAL OF CANCER, 2003, 88 : S36 - S36
  • [6] Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcoma
    Zhang Jingzhe
    Li Ye
    Yang Shoujun
    Zhang Lening
    Wang Wenjun
    JOURNAL OF BONE ONCOLOGY, 2019, 17
  • [7] PRECLINICAL CHARACTERIZATION OF A HIGHLY SELECTIVE AND POTENT ANTAGONISTIC ANTI-CD40 MAB
    Ralph, K.
    Nicoletti, A.
    Musvasva, E.
    Cannan, S.
    VanTongeren, S.
    Blanset, D.
    Brodeur, S.
    Ahlberg, J.
    Li, H.
    Fogal, S.
    Desai, S.
    O'Shea, K.
    Kroe-Barrett, R.
    Mainolfi, E.
    Nabozny, G.
    Wu, H.
    Hansen, G.
    Canada, K.
    Singh, S.
    Zhu, X.
    Ramanujam, M.
    Grimaldi, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 344 - 344
  • [8] The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb
    Ferlin, WG
    von der Weid, T
    Cottrez, F
    Ferrick, DA
    Coffman, RL
    Howard, MC
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (02) : 525 - 531
  • [9] Distinctive maturation of in vitro versus in vivo anti-CD40 mAb-matured dendritic cells in mice
    Frleta, D
    Lin, JT
    Quezada, SA
    Wade, TK
    Barth, RJ
    Noelle, RJ
    Wade, WF
    JOURNAL OF IMMUNOTHERAPY, 2003, 26 (01): : 72 - 84
  • [10] Therapeutic activity of agonistic anti-CD40 mAb in a chronic autoimmune inflammatory process
    Mauri, C
    Mars, LT
    Londei, M
    FASEB JOURNAL, 2000, 14 (06): : A1101 - A1101
12345